Heres whats happening in real life: Rapid weight loss = volume loss in the face Volume loss = sagging or hollow appearance People then seek skin tightening or rejuvenation treatments Ironically, GLP-1 medications may increase demand for professional facial treatments
Regulatory status (as of publication): Not approved by the FDA, EMA, or any other regulatory authority for any indication
Furthermore, these low-resolution techniques were used long before the scientific community fully accepted the concept of biologically active proteins lacking a fixed 3D structure, and were instrumental in laying the groundwork for this vital discovery, played a crucial role in the discovery of the protein intrinsic disorder phenomenon and, later, offered tremendous help with establishing the IDP/IDR field
Drug Interactions Drug Interactions Affecting Co-administered Drugs: Antibiotics: Thiamine, riboflavin, pyridoxine, niacinamide and ascorbic acid decrease activities of erythromycin, kanamycin, streptomycin, doxycycline and lincomycin (7.1) Bleomycin: Ascorbic acid and riboflavin may reduce the activity of bleomycin (7.1) Levodopa: Pyridoxine may decrease blood levels of levodopa and levodopa efficacy may decrease (7.1) Phenytoin: Folic acid may decrease phenytoin blood levels and increase risk of seizure (7.1) Methotrexate: Folic acid may decrease response to methotrexate (7.1) Drug Interactions Affecting Vitamin Levels: Use In Specific Populations See 17 for PATIENT COUNSELING INFORMATION
